ML19253B171

From kanterella
Revision as of 02:53, 8 October 2019 by StriderTol (talk | contribs) (Created page by program invented by StriderTol)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Options for Exubrion Therapeutics, Inc.'S Continued Discussions on the Use of Sn-117m in Dogs for the Treatment of Osteoarthritis
ML19253B171
Person / Time
Issue date: 09/10/2019
From:
Office of Nuclear Material Safety and Safeguards
To:
Wu, Irene
References
Download: ML19253B171 (1)


Text